A citation-based method for searching scientific literature

Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh. Medicine (Baltimore) 2016
Times Cited: 10







List of co-cited articles
45 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Yung-Kuan Tsou, Kung-Hao Liang, Wey-Ran Lin, Hsien-Kun Chang, Chen-Kan Tseng, Chau-Ting Yeh. Oncotarget 2017
9
66



A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Chau-Ting Yeh, Kung-Hao Liang, Chen-Chun Lin, Ming-Ling Chang, Cheng-Lung Hsu, Chien-Fu Hung. Int J Cancer 2014
18
50


GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
42
40

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
440
40

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
427
40

GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Kung-Hao Liang, Chih-Lang Lin, Sung-Fang Chen, Chih-Wei Chiu, Pei-Ching Yang, Ming-Ling Chang, Chen-Chun Lin, Kai-Feng Sung, Cassandra Yeh, Chien-Fu Hung,[...]. Pharmacogenomics 2016
11
40

Identification of GALNT14 as a novel neuroblastoma predisposition gene.
Marilena De Mariano, Roberta Gallesio, Marco Chierici, Cesare Furlanello, Massimo Conte, Alberto Garaventa, Michela Croce, Silvano Ferrini, Gian Paolo Tonini, Luca Longo. Oncotarget 2015
27
40

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
45
30


Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
30

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
30

GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ya-Hui Huang, Chau-Ting Yeh. Mol Clin Oncol 2014
10
30

Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
Tsung-Hsing Chen, Wey-Ran Lin, Chieh Lee, Cheng-Tang Chiu, Jun-Te Hsu, Ta-Sen Yeh, Kwang-Huei Lin, Puo-Hsien Le, Chau-Ting Yeh. J Cancer 2018
7
42

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
Ki-Hoon Song, Mi So Park, Tulip S Nandu, Shrikanth Gadad, Sang-Cheol Kim, Mi-Young Kim. Nat Commun 2016
29
30

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Ok-Seon Kwon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, Yoon L Choi, Young Soo Choi, Jhingook Kim,[...]. Oncotarget 2015
20
20

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, Barna Szima, István Albert, Erzsébet Juhász, Jean-Louis Pujol, Jerzy Kozielski, Nigel Baker, Dominic Smethurst,[...]. J Clin Oncol 2011
172
20

Glycans in cancer and inflammation--potential for therapeutics and diagnostics.
Danielle H Dube, Carolyn R Bertozzi. Nat Rev Drug Discov 2005
20

Protein glycosylation in cancer.
Sean R Stowell, Tongzhong Ju, Richard D Cummings. Annu Rev Pathol 2015
349
20

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
340
20

A little sugar goes a long way: the cell biology of O-GlcNAc.
Michelle R Bond, John A Hanover. J Cell Biol 2015
306
20


Vertebrate protein glycosylation: diversity, synthesis and function.
Kelley W Moremen, Michael Tiemeyer, Alison V Nairn. Nat Rev Mol Cell Biol 2012
861
20

O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
Christina M Ferrer, Thomas P Lynch, Valerie L Sodi, John N Falcone, Luciana P Schwab, Danielle L Peacock, David J Vocadlo, Tiffany N Seagroves, Mauricio J Reginato. Mol Cell 2014
192
20

Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
Kyoung Ah Kang, Mei Jing Piao, Yea Seong Ryu, Hee Kyoung Kang, Weon Young Chang, Young Sam Keum, Jin Won Hyun. Oncotarget 2016
34
20

Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
Agata Steenackers, Stéphanie Olivier-Van Stichelen, Steffi F Baldini, Vanessa Dehennaut, Robert-Alain Toillon, Xuefen Le Bourhis, Ikram El Yazidi-Belkoura, Tony Lefebvre. Front Endocrinol (Lausanne) 2016
27
20

O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Wenyi Mi, Yuchao Gu, Cuifang Han, Haiyan Liu, Qiong Fan, Xinling Zhang, Qi Cong, Wengong Yu. Biochim Biophys Acta 2011
165
20

Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
Shiv Ram Krishn, Sukhwinder Kaur, Lynette M Smith, Sonny L Johansson, Maneesh Jain, Asish Patel, Shailendra K Gautam, Michael A Hollingsworth, Ulla Mandel, Henrik Clausen,[...]. Cancer Lett 2016
37
20

Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.
Patricia Carvalho-Cruz, Frederico Alisson-Silva, Adriane R Todeschini, Wagner B Dias. Dev Dyn 2018
24
20

Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
Toshie Iwai, Takashi Kudo, Risa Kawamoto, Tomomi Kubota, Akira Togayachi, Toru Hiruma, Tomoko Okada, Toru Kawamoto, Kyoei Morozumi, Hisashi Narimatsu. Proc Natl Acad Sci U S A 2005
105
20

Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Guillaume Piessen, Mathieu Messager, Emmanuelle Leteurtre, Triboulet Jean-Pierre, Christophe Mariette. Ann Surg 2009
191
20

Mucin-type O-glycosylation during development.
Duy T Tran, Kelly G Ten Hagen. J Biol Chem 2013
146
20


Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.
Wey-Ran Lin, Chao-Wei Hsu, Christopher Sung-Huan Yeh, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Chen-Chun Lin, Yu-De Chu, Chau-Ting Yeh. Asia Pac J Clin Oncol 2018
5
40

T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
Xichen Dong, Yuliang Jiang, Jian Liu, Zhe Liu, Tianbo Gao, Guangyu An, Tao Wen. Biomed Res Int 2018
8
25

EMT in cancer.
Thomas Brabletz, Raghu Kalluri, M Angela Nieto, Robert A Weinberg. Nat Rev Cancer 2018
762
20

De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.
Kirstine Lavrsen, Sally Dabelsteen, Sergey Y Vakhrushev, Asha M R Levann, Amalie Dahl Haue, August Dylander, Ulla Mandel, Lars Hansen, Morten Frödin, Eric P Bennett,[...]. J Biol Chem 2018
38
20

Cosmc overexpression enhances malignancies in human colon cancer.
Tianbo Gao, Tan Du, Xin Hu, Xichen Dong, Lina Li, Yakun Wang, Jian Liu, Lijie Liu, Tao Gu, Tao Wen. J Cell Mol Med 2020
5
40

Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
Zhe Liu, Jian Liu, Xichen Dong, Xin Hu, Yuliang Jiang, Lina Li, Tan Du, Lei Yang, Tao Wen, Guangyu An,[...]. J Cell Mol Med 2019
12
20

Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Xiaodong Sun, Tongzhong Ju, Richard D Cummings. BMC Cancer 2018
23
20

Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Yuliang Jiang, Zhe Liu, Feng Xu, Xichen Dong, Yurong Cheng, Yizhang Hu, Tianbo Gao, Jian Liu, Lei Yang, Xingyuan Jia,[...]. J Cell Mol Med 2018
17
20

Advances in pancreatic cancer biomarkers.
Syed Hasan, Rojymon Jacob, Upender Manne, Ravi Paluri. Oncol Rev 2019
37
20

Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.
Han Wang, Kouichi Tachibana, Yan Zhang, Hiroko Iwasaki, Akihiko Kameyama, Lamei Cheng, Jian ming Guo, Toru Hiruma, Akira Togayachi, Takashi Kudo,[...]. Biochem Biophys Res Commun 2003
70
20

The role of mucin-type O-glycans in eukaryotic development.
Lawrence A Tabak. Semin Cell Dev Biol 2010
46
10

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
60
10

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
83
10

TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.
Andrew Thorburn, Kian Behbakht, Heide Ford. Drug Resist Updat 2008
128
10

Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
Mamadou Keita, Zhi-Qiang Wang, Jean-Francois Pelletier, Magdalena Bachvarova, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Anne-Marie Mes-Masson, Éric R Paquet, Dimcho Bachvarov. Gynecol Oncol 2013
42
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.